Skip to content
etf.net

Launched · SEC filings

First Trust Indxx Medical Devices ETF

MDEVCboeFirst TrustD

$22.06+0.21 (+0.96%)

At close: Nov 2, 2026, 4:00 PM ET

D27/ 100

Rank 22 of 25 in Health Care (Broad)

D27/100Rank 22 of 25inHealth Care (Broad)
Intraday session: up, 73 prints from 21.85 to 22.06. Range 21.85 to 22.17. Use the arrow keys to read each point.21.9021.9522.0022.1022.1510 AM12 PM2 PM4 PM
Expense ratio
0.70%
Fund size
$3M
1Y total return
+7.8%
Yield · Last 12 months
No data
Holdings
53
Avg volume · 30D
2.5K sh
52W range
low $17.85high $22.82
Launched
Filings
SEC EDGAR

The ETF.net MDEV Grade

D

Score 27 out of 100

Category
Health Care (Broad)⁠
Rank
22 of 25
Six-pillar profile for MDEV. Scores out of 100: Cost 17, Risk 37, Mission 77, Tradability 11, Holdings 75, Durability 23. Strongest: Mission (77). Weakest: Tradability (11). Leans toward Mission and Holdings.

Score 27 of 100 falls in the D band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

Very small fund, grade capped at C.

The cap holds the Score at 40 or below, so B and A are out of reach.

The pillars earned
28
This cap took
0
Published Score
27 Grade D

  • Cost

    The fund’s net expense ratio, ranked against its category.
    F17 out of 100
    Rank 21 of 25

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    A77 out of 100
    Rank 6 of 11

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    D37 out of 100
    Rank 17 of 25

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    F11 out of 100
    Rank 24 of 25

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    A75 out of 100
    Rank 7 of 25

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    F23 out of 100
    Rank 22 of 25

Our read on MDEV

ETF.net Research

In short

DMedical devices, worldwide and evenly sliced. MDEV tracks a global index of roughly 50 device and equipment makers in similar-sized weights, so a mid-cap scanner or surgical-robot maker counts about as much as the household-name giants.

Stated mandate

The Fund seeks to track the performance of the Indxx Medical Devices Index before fees and expenses, using an indexing approach.

Why people hold it

  • Pure play by design: the index covers the medical equipment industry only, and at least 80% of net assets go into its constituents. No pharma or insurers riding along.usnews.com
  • Equal weighting keeps one mega-cap from running the show. About 50 device names get similar-sized slices, pushing real weight toward the mid-sized makers.public.comrobinhood.com
  • Global by mandate, not US-only: the fund holds common stocks and depositary receipts from device makers listed outside the States, using plain physical index replication.businesswire.comusnews.com

Worth knowing

  • At 0.70% a year, it costs more than the typical global thematic fund, and well above cheaper cohort names like PBPH (0.13%) or UFOX (0.30%).
  • Small and thinly traded: spreads can run wide, and sub-scale funds face a higher chance of closure or merger than their bigger shelf-mates.
  • One industry, about 50 stocks. Reimbursement rules, hospital budgets and regulators move the whole basket at once, and payouts come once or twice a year.

MDEV Performance

Launched Jun 22, 2021

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.
MDEV$10,784
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,146
Oct 31, 2025 to Nov 2, 2026. MDEV $10,784. SPY $11,146. Use the arrow keys to read each point.$9,000$10,000$11,000Oct 2025May 2026Nov 2026

Oct 31, 2025 – Nov 2, 2026

Returns run to the Nov 2, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for MDEV. Periods over one year show the average yearly return.
PeriodMDEV
Year to date+5.3%
1 month+7.9%
3 months+9.0%
1 year+7.8%
3 yearsper year+8.7%
5 yearsper year−3.7%
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for MDEV
YearReturn barMDEV
2026 YTD+5.3%
2025+2.0%
2024+1.8%
2023+7.6%
2022−28.6%
2021+3.8%

History from Jun 24, 2021

MDEV in the news

MDEV Dividends

Last payment
$0.02 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Irregular

Distribution data unavailable.

Distribution history

2026

One bar per payment. 1 payment in 2026 YTD. Jun 25, 2026 $0.02. Use the arrow keys to read each point.2026YTD
Ex-datePay dateAmount per share
Jun 25, 2026Jun 30, 2026$0.02

$10,000 in MDEV 5 years ago paid $8.33 in dividends.

MDEV Risk

Risk pillarD37 out of 100Rank 17 of 25 in Health Care (Broad)
How much the fund’s monthly returns vary, scaled to a year.
15.7%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.37
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−39.5%
Trough Sep 2022
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.86
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

MDEV Cost

Compare MDEV and XLV

Overpaying vs XLV, cheapest in Health Care (Broad)

$11,917

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • MDEV 0.70%

    $13,606

  • XLV 0.08% Cheapest

    $1,689

$10,000
30 years

Cost over time

  • MDEV 0.70%
  • XLV 0.08%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K051015202530MDEV $13,606XLV $1,689

Year by year

YearMDEVXLVOverpaying
10$1,250$147$1,103
20$4,760$575$4,185
30$13,606$1,689$11,917

Other funds in Health Care (Broad)

See others